Bruker Net Change in Short-term Investments 2010-2024 | BRKR

Bruker annual/quarterly net change in short-term investments history and growth rate from 2010 to 2024. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
  • Bruker net change in short-term investments for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Bruker net change in short-term investments for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • Bruker annual net change in short-term investments for 2024 was $0B, a 0% decline from 2023.
  • Bruker annual net change in short-term investments for 2023 was $0B, a 100% decline from 2022.
  • Bruker annual net change in short-term investments for 2022 was $0.1B, a 300.8% decline from 2021.
Bruker Annual Net Change in Short-term Investments
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $100
2021 $-50
2020 $-44
2019 $-6
2018 $117
2017 $68
2016 $39
2015 $-41
2014 $-193
2013 $N/A
2012 $N/A
2011 $N/A
2010 $N/A
2009 $N/A
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $5.687B $3.366B
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
Stock Name Country Market Cap PE Ratio
Kewaunee Scientific (KEQU) United States $0.107B 7.49
Harvard Bioscience (HBIO) United States $0.015B 0.00